Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amindo Biologics is a commercial-stage company providing a broad portfolio of in-vitro diagnostic kits and reagents—including ELISA, LIA, CLIA, FIA—and research products such as proteins, antibodies, antigens, DNA/RNA probes. The company also develops biosimilars and recombinant proteins for research use. It has demonstrated rapid growth over the past several years with a focus on quality assurance and global reach. No clinical trial results are reported; the company's main business is diagnostics rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amindo Biologics.